Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,848
Closed -$392K 453
2024
Q3
$392K Buy
5,848
+2,084
+55% +$171K 0.19% 110
2024
Q2
$427K Sell
3,764
-780
-17% -$98.6K 0.22% 81
2024
Q1
$630K Sell
4,544
-1,802
-28% -$227K 0.23% 100
2023
Q4
$787K Buy
6,346
+875
+16% +$89.4K 0.25% 82
2023
Q3
$510K Buy
5,471
+2,702
+98% +$305K 0.26% 94
2023
Q2
$356K Buy
2,769
+1,020
+58% +$123K 0.17% 172
2023
Q1
$203K Buy
+1,749
New +$196K 0.14% 241

Other funds holding DXCM

Corton Capital's DXCM Position: Q4 2024 in Review

Corton Capital sold out of DexCom (DXCM) in Q4 2024, closing a stake of 5,848 shares — an estimated $392K sold.

Corton Capital first reported a position in DXCM in Q1 2023 and held it in 7 quarters. The position peaked at $787K in Q4 2023. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Corton Capital reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Corton Capital sold 5,848 DexCom shares in Q4 2024, an estimated $392K.
  • Corton Capital first reported a position in DexCom in Q1 2023 and held it in 7 quarters.
  • Corton Capital's DexCom position peaked at $787K in Q4 2023.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.